Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.

Yozgatli, K; Lefrandt, J D; Noordzij, M J; Oomen, P H N; Brouwer, T; Jager, J; Castro Cabezas, M; Smit, A J

Yozgatli, K; Lefrandt, J D; Noordzij, M J; Oomen, P H N; Brouwer, T; Jager, J; Castro Cabezas, M; Smit, A J.

Afiliação

Yozgatli K; Department of Internal Medicine, University of Groningen, University Medical Centre Groningen.
Lefrandt JD; Department of Internal Medicine, University of Groningen, University Medical Centre Groningen.
Noordzij MJ; Department of Internal Medicine, University of Groningen, University Medical Centre Groningen.
Oomen PHN; Department of Internal Medicine, Medical Centre Leeuwarden.
Brouwer T; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam.
Jager J; Department of Internal Medicine, Het Diakonessenhuis, Meppel.
Castro Cabezas M; Department of Internal Medicine, Sint Franciscus Gasthuis Rotterdam, The Netherlands.
Smit AJ; Department of Internal Medicine, University of Groningen, University Medical Centre Groningen.

Diabet Med ; 2018 Apr 23.

Article em En | MEDLINE | ID: mdl-29687658

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google